دورية أكاديمية

Dopaminergic mesolimbic structural reserve is positively linked to better outcome after severe stroke.

التفاصيل البيبلوغرافية
العنوان: Dopaminergic mesolimbic structural reserve is positively linked to better outcome after severe stroke.
المؤلفون: Asmussen L; University Medical Center Hamburg-Eppendorf, Department of Neurology, 20246 Hamburg, Germany., Frey BM; University Medical Center Hamburg-Eppendorf, Department of Neurology, 20246 Hamburg, Germany., Frontzkowski LK; University Medical Center Hamburg-Eppendorf, Department of Neurology, 20246 Hamburg, Germany., Wróbel PP; University Medical Center Hamburg-Eppendorf, Department of Neurology, 20246 Hamburg, Germany., Grigutsch LS; University Medical Center Hamburg-Eppendorf, Department of Neurology, 20246 Hamburg, Germany., Choe CU; University Medical Center Hamburg-Eppendorf, Department of Neurology, 20246 Hamburg, Germany., Bönstrup M; University Medical Center Hamburg-Eppendorf, Department of Neurology, 20246 Hamburg, Germany.; University Medical Center Leipzig, Department of Neurology, 04103 Leipzig, Germany., Cheng B; University Medical Center Hamburg-Eppendorf, Department of Neurology, 20246 Hamburg, Germany., Thomalla G; University Medical Center Hamburg-Eppendorf, Department of Neurology, 20246 Hamburg, Germany., Quandt F; University Medical Center Hamburg-Eppendorf, Department of Neurology, 20246 Hamburg, Germany., Gerloff C; University Medical Center Hamburg-Eppendorf, Department of Neurology, 20246 Hamburg, Germany., Schulz R; University Medical Center Hamburg-Eppendorf, Department of Neurology, 20246 Hamburg, Germany.
المصدر: Brain communications [Brain Commun] 2024 Apr 09; Vol. 6 (3), pp. fcae122. Date of Electronic Publication: 2024 Apr 09 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755125 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-1297 (Electronic) Linking ISSN: 26321297 NLM ISO Abbreviation: Brain Commun Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Oxford] : Oxford University Press, [2019]-
مستخلص: The concept of brain reserve capacity has emerged in stroke recovery research in recent years. Imaging-based biomarkers of brain health have helped to better understand outcome variability in clinical cohorts. Still, outcome inferences are far from being satisfactory, particularly in patients with severe initial deficits. Neurorehabilitation after stroke is a complex process, comprising adaption and learning processes, which, on their part, are critically influenced by motivational and reward-related cognitive processes. Amongst others, dopaminergic neurotransmission is a key contributor to these mechanisms. The question arises, whether the amount of structural reserve capacity in the dopaminergic system might inform about outcome variability after severe stroke. For this purpose, this study analysed imaging and clinical data of 42 severely impaired acute stroke patients. Brain volumetry was performed within the first 2 weeks after the event using the Computational Anatomy Toolbox CAT12, grey matter volume estimates were collected for seven key areas of the human dopaminergic system along the mesocortical, mesolimbic and nigrostriatal pathways. Ordinal logistic regression models related regional volumes to the functional outcome, operationalized by the modified Rankin Scale, obtained 3-6 months after stroke. Models were adjusted for age, lesion volume and initial impairment. The main finding was that larger volumes of the amygdala and the nucleus accumbens at baseline were positively associated with a more favourable outcome. These data suggest a link between the structural state of mesolimbic key areas contributing to motor learning, motivational and reward-related brain networks and potentially the success of neurorehabilitation. They might also provide novel evidence to reconsider dopaminergic interventions particularly in severely impaired stroke patients to enhance recovery after stroke.
Competing Interests: The authors report no competing interests.
(© The Author(s) 2024. Published by Oxford University Press on behalf of the Guarantors of Brain.)
التعليقات: Erratum in: Brain Commun. 2024 Jun 06;6(3):fcae191. doi: 10.1093/braincomms/fcae191. (PMID: 38846533)
References: Chronic Stress (Thousand Oaks). 2020 Sep 22;4:2470547020944553. (PMID: 33015518)
Elife. 2022 Feb 03;11:. (PMID: 35113016)
Brain Commun. 2022 Aug 04;4(6):fcac203. (PMID: 36337341)
Science. 2015 Oct 2;350(6256):98-101. (PMID: 26430122)
Lancet Neurol. 2019 Jun;18(6):530-538. (PMID: 31122493)
Brain Commun. 2021 Jun 11;3(3):fcab125. (PMID: 34222873)
Psychoneuroendocrinology. 1981;6(1):3-16. (PMID: 7017786)
J Cell Mol Med. 2012 Sep;16(9):1961-9. (PMID: 22348642)
Brain Sci. 2024 Jan 12;14(1):. (PMID: 38248292)
Front Neurol. 2021 Sep 10;12:700616. (PMID: 34566844)
Int J Stroke. 2021 Nov 3;:17474930211055906. (PMID: 34730044)
Lancet. 2011 May 14;377(9778):1693-702. (PMID: 21571152)
J Neurosci. 2009 Jan 14;29(2):436-43. (PMID: 19144843)
Lancet Neurol. 2019 Jun;18(6):514-515. (PMID: 31122485)
Behav Brain Res. 2015 Oct 15;293:54-61. (PMID: 26166190)
Brain. 2018 Mar 1;141(3):797-810. (PMID: 29360949)
Ann Clin Transl Neurol. 2016 Jan 19;3(3):233-44. (PMID: 27042683)
Brain Res. 2018 Jan 1;1678:146-152. (PMID: 29079503)
Neurosurgery. 2016 Aug;79(2):204-11. (PMID: 26702839)
Hum Brain Mapp. 2023 Apr 1;44(5):1888-1900. (PMID: 36583562)
Neurorehabil Neural Repair. 2018 Aug;32(8):682-690. (PMID: 29972088)
Front Synaptic Neurosci. 2018 Jul 06;10:18. (PMID: 30034335)
J Neurol Neurosurg Psychiatry. 2017 Sep;88(9):737-743. (PMID: 28642286)
Soc Cogn Affect Neurosci. 2016 Oct;11(10):1521-7. (PMID: 27217105)
Mayo Clin Proc. 2020 May;95(5):955-965. (PMID: 32370856)
Neurorehabil Neural Repair. 2017 Sep;31(9):793-799. (PMID: 28934920)
Brain. 2020 May 1;143(5):1525-1540. (PMID: 32357220)
Neuron. 2010 Dec 9;68(5):815-34. (PMID: 21144997)
Lancet. 2001 Sep 8;358(9284):787-90. (PMID: 11564483)
Neuroimage Clin. 2019;24:102036. (PMID: 31698315)
Continuum (Minneap Minn). 2021 Dec 1;27(6):1586-1601. (PMID: 34881727)
Brain Sci. 2022 Mar 01;12(3):. (PMID: 35326289)
Brain Res. 1982 Feb 18;234(1):53-63. (PMID: 6120746)
Front Neurol. 2022 Jun 03;13:856919. (PMID: 35720079)
Neuroimage Clin. 2016 Sep 24;13:310-319. (PMID: 28053857)
Brain Commun. 2021 Oct 27;3(4):fcab254. (PMID: 34805997)
PM R. 2022 Mar;14(3):329-336. (PMID: 33728742)
Brain Struct Funct. 2021 Apr;226(3):685-700. (PMID: 33442810)
Ann Neurol. 2019 Dec;86(6):853-865. (PMID: 31604371)
Curr Biol. 2011 Apr 12;21(7):557-62. (PMID: 21419628)
J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):369-378. (PMID: 34937750)
Mol Psychiatry. 2022 Mar;27(3):1704-1711. (PMID: 34862441)
Neuropharmacology. 2014 Jan;76 Pt B:351-9. (PMID: 23578393)
iScience. 2021 Jul 07;24(7):102821. (PMID: 34345810)
Learn Mem. 2004 Jul-Aug;11(4):388-96. (PMID: 15286181)
Nat Neurosci. 2015 Apr;18(4):597-602. (PMID: 25706473)
Prog Brain Res. 2016;229:303-323. (PMID: 27926445)
Front Neurol. 2022 Feb 24;13:823202. (PMID: 35280288)
Cell Transplant. 2017 Jul;26(7):1156-1168. (PMID: 28933212)
Sci Rep. 2021 May 26;11(1):11000. (PMID: 34040100)
Brain Res Bull. 1994;33(3):281-8. (PMID: 7904889)
Curr Opin Neurobiol. 2009 Dec;19(6):615-20. (PMID: 19896833)
Handb Clin Neurol. 2019;167:181-190. (PMID: 31753132)
Psychon Bull Rev. 2016 Oct;23(5):1382-1414. (PMID: 26833314)
Neurorehabil Neural Repair. 2022 Feb;36(2):140-150. (PMID: 34937456)
PLoS One. 2015 May 04;10(5):e0124986. (PMID: 25938462)
J Neurochem. 1988 Nov;51(5):1455-64. (PMID: 2902196)
J Neurol Neurosurg Psychiatry. 2017 Sep;88(9):730-736. (PMID: 28377451)
J Neurosci. 2005 Mar 16;25(11):2771-80. (PMID: 15772337)
Neuroimage. 2007 Oct 15;38(1):95-113. (PMID: 17761438)
Neuroimage. 2020 Feb 1;206:116189. (PMID: 31521825)
J Neurochem. 1993 Jan;60(1):128-36. (PMID: 8417136)
Trends Neurosci. 2007 May;30(5):194-202. (PMID: 17408759)
Int Arch Med. 2010 Oct 06;3:24. (PMID: 20925949)
Brain Commun. 2021 May 04;3(2):fcab097. (PMID: 34056601)
Stroke. 2018 Dec;49(12):2928-2932. (PMID: 30571408)
Brain Commun. 2021 Sep 06;3(3):fcab211. (PMID: 34557668)
IEEE Trans Neural Syst Rehabil Eng. 2012 Jan;20(1):48-57. (PMID: 22186963)
Stroke. 2021 Mar;52(3):1004-1011. (PMID: 33504185)
Neurorehabil Neural Repair. 2020 Mar;34(3):187-199. (PMID: 32089097)
Mol Neurodegener. 2019 Aug 20;14(1):35. (PMID: 31488222)
Brain. 1993 Apr;116 ( Pt 2):369-82. (PMID: 8461971)
Cereb Cortex. 2022 Dec 8;32(24):5622-5627. (PMID: 35169830)
Sci Rep. 2021 Feb 24;11(1):4478. (PMID: 33627742)
EXS. 1992;62:199-212. (PMID: 1360281)
Neurology. 1988 Mar;38(3):388-90. (PMID: 3347342)
Brain Commun. 2022 Feb 22;4(2):fcac049. (PMID: 35274100)
Lancet Neurol. 2021 Oct;20(10):795-820. (PMID: 34487721)
Ann Neurol. 2016 Oct;80(4):581-92. (PMID: 27518166)
Neurol Res Pract. 2020 Jun 16;2:17. (PMID: 33324923)
Neurology. 2023 Feb 21;100(8):e822-e833. (PMID: 36443016)
Curr Opin Neurol. 2006 Feb;19(1):84-90. (PMID: 16415682)
فهرسة مساهمة: Keywords: brain reserve; cognition; dopamine; grey matter; voxel-based morphometry
تواريخ الأحداث: Date Created: 20240507 Latest Revision: 20240607
رمز التحديث: 20240607
مُعرف محوري في PubMed: PMC11073754
DOI: 10.1093/braincomms/fcae122
PMID: 38712322
قاعدة البيانات: MEDLINE
الوصف
تدمد:2632-1297
DOI:10.1093/braincomms/fcae122